CD274 and breast carcinoma: In addition, binding of hepatitis B virus X-interacting protein (HBXIP) to P300 in breast cancer enhances acetylation of the PD-L1 K270 site, leading to stabilization and accumulation of PD-L1 in cancer cells, thereby enhancing tumor immune escape (121).